Ryan Specialty Holdings, Inc.

Valuation Analysis

About the Company

Ryan Specialty Holdings, Inc. en bref

Ryan Specialty Holdings, Inc. (RYAN) is currently trading at 30,49 € with a market capitalization of 8,0 Md €. The trailing P/E ratio stands at 42.65x, with a forward P/E of 14.92x. The 52-week range spans from 25,53 € to 60,58 €; the current price is 49.7% below the yearly high. Year-over-year revenue growth stands at +15.8%. The net profit margin stands at 3.5%.

💰 Dividende

Ryan Specialty Holdings, Inc. pays an annual dividend of 0,45 € per share, representing a yield of 1.49%. The payout ratio stands at 59.76%.

📊 Avis des analystes

17 analystes évaluent Ryan Specialty Holdings, Inc. (RYAN) au consensus : Acheter. L'objectif de cours moyen est de 37,02 €, soit un potentiel de +21.45% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 27,02 € à 66,25 €.

Ryan Specialty Holdings, Inc. : la thèse d'investissement en détail

Ryan Specialty Holdings, Inc. (RYAN) operates in the Financial Services — specifically Insurance - Specialty — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 15.8% pace year-over-year, suggesting the business model continues to find new customers and pricing power. The combination of a 41.77% gross margin and 17.37% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat. Wall Street consensus sits at Buy with an average price target implying roughly 21.45% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

With a net margin of just 3.5%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. The debt-to-equity ratio of 307.01% is elevated, meaning the company relies heavily on creditors — refinancing terms will become more important than operational performance in the next economic downturn. Short interest sits at 11.54% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

Valorisation en contexte

The EV/EBITDA multiple of 9.8x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

À surveiller

• The forward P/E of 14.92x is meaningfully below the trailing 42.65x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 21.45% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (11.54%), higher leverage relative to equity.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy Ryan Specialty Holdings, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.